Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
0 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Dare Bioscience, Inc.’s names, not what it holds today.
Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
28
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
CERULEAN PHARMA INC. a former name
named as the applicant on its applications, in US
24 publishedDaré Bioscience, Inc. its own name
named as the applicant on its applications, in US
4 published
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jul 25, 2024 | 2024/0245547 | INTRAVAGINAL RING DEVICES | Pharmaceuticals | Daré Bioscience, Inc. |
| Jun 13, 2024 | 2024/0189265 | COMPOSITIONS AND TECHNIQUES FOR VAGINAL INSERTION | Pharmaceuticals | Daré Bioscience, Inc. |
| May 23, 2024 | 2024/0165141 | SYSTEMS AND METHODS FOR TREATMENT OF BACTERIAL VAGINOSIS | Pharmaceuticals | Daré Bioscience, Inc. |
| Sep 9, 2021 | 2021/0275347 | INTRAVAGINAL RING DEVICES | Pharmaceuticals | Daré Bioscience, Inc. |
| Dec 13, 2018 | 2018/0355071 | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES | Macromolecular chemistry, polymers | CERULEAN PHARMA INC. |
| Sep 20, 2018 | 2018/0264136 | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES | Pharmaceuticals | CERULEAN PHARMA INC. · patent 11,464,871 granted from it |
| Jul 12, 2018 | 2018/0193486 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE | Pharmaceuticals | CERULEAN PHARMA INC. |
| Apr 26, 2018 | 2018/0110791 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | Pharmaceuticals | CERULEAN PHARMA INC. |
| Mar 15, 2018 | 2018/0071404 | TREATMENT OF CANCER | Pharmaceuticals | CERULEAN PHARMA INC. |
| Jan 18, 2018 | 2018/0015170 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | Pharmaceuticals | CERULEAN PHARMA INC. |
What it applied for, 2024 to 2025: Pharmaceuticals 3.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.